Intellipharmaceutics International Inc. (IPCI)

[doogdilinger]

Samsa...please feel free to show me where I've supposedly tried to twist anything lmao? I've copied/pasted a couple of sections of earnings which if you don't like so be it...but calling that me supposedly twisting anything is pure and utter hogwash lmao!

And you have no clue when they're going to sign Rexista partnership or whether they're going to need to raise monies by June.

IPCI like all PubCo's is of course going to put into their fins the standard boilerplate potential financing language in case that possibility is eventually required...as they have done in every single earnings report since this company's publicly traded inception lol.

But whether they do so or not is going to depend on how much revenue increase they got from their profit sharing deal with PAR on PAR's commercialized FocalinXR strengths this Q...and how much revenue increase they're going to get from their licensing deal with Mallinkrodt on SeroquelXR commercialization beginning during IPCI's fiscal Q2...which will kick in during the last month of IPCI's fiscal Q2.

And regardless of how much revenue increase IPCI gets during fiscal Q1 and Q2...only IPCI and their potential Rexista partner know if/when the Rexista partnership could hit which will be a game changer.

Plus we don't know when the FDA is going to hand down the next ANDA approvals or when IPCI's going to secure more ANDA licensing agreements.

So stating that you know for sure IPCI's supposedly going to dilute is false...as the possibly of eventual dilution has always existed for IPCI yet Dr Odidi has consistently remained as frugal as CEO's come when it comes to doing any market raises glty